Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 66 of 124)
- Relevance
  Sort by

Anti-Ischemic Agents - Global Strategic Business Report

 Report
November 2024
94 Pages
Global

From

€5530EUR$5,600USD£4,618GBP

Fondaparinux - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5530EUR$5,600USD£4,618GBP

North America Cancer Vaccines Market- Growth, Trends, and Forecast(2022 - 2027)

 Report
January 2022
90 Pages
North America

From

€4690EUR$4,750USD£3,917GBP

Europe Cancer Vaccines Market- Growth, Trends, and Forecast(2022 - 2027)

 Report
January 2022
90 Pages
Europe

From

€4690EUR$4,750USD£3,917GBP

Heparin - Global Strategic Business Report

 Report
November 2024
184 Pages
Global

From

€4888EUR$4,950USD£4,082GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Heart Failure Drugs - Global Strategic Business Report

 Report
November 2024
179 Pages
Global

From

€4888EUR$4,950USD£4,082GBP

Vasculitis Treatment - Global Strategic Business Report

 Report
November 2024
183 Pages
Global

From

€4888EUR$4,950USD£4,082GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
November 2024
413 Pages
Global

From

€5382EUR$5,450USD£4,494GBP

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

 Report
November 2024
188 Pages
Global

From

€5382EUR$5,450USD£4,494GBP

Live Biotherapeutic Products and Microbiome Manufacturing Market by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
February 2022
305 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024

 Clinical Trials
August 2024
60 Pages
Global

From

€864EUR$875USD£721GBP

€1234EUR$1,250USD£1,031GBP

Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer including Executive and Consultant Guides. 2023 to 2027

 Report
November 2024
256 Pages
Global

From

€6907EUR$6,995USD£5,768GBP

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
September 2022
799 Pages
Global

From

€4739EUR$4,799USD£3,957GBP

Global BCR ABL Tyrosine Kinase Inhibitor Drug Market, Drug Price, Sales & Clinical Trials Insight 2029

 Report
June 2023
240 Pages
Global

From

€2370EUR$2,400USD£1,979GBP

Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report

 Report
July 2024
299 Pages
Global

From

€5382EUR$5,450USD£4,494GBP

Cardiovascular and Cerebrovascular Diseases Market (2023 Edition): Analysis By Drug Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2029

 Report
August 2023
230 Pages
Global

From

€2419EUR$2,450USD£2,020GBP

Global Breast Cancer Immunotherapy Market & Clinical Trials Forecast 2028

 Report
June 2023
720 Pages
Global

From

€4147EUR$4,200USD£3,463GBP

Antidepressants Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Acute Agitation And Aggression Treatment Market Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Active Pharmaceutical Ingredient (API) Market in US 2024-2028

 Report
February 2024
147 Pages
United States

From

€2469EUR$2,500USD£2,061GBP

2,461 Results (Page 66 of 124)
- 1
- 64
- 65
- 66
- 67
- 68

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.